High levels of circulating free FA and impaired insulin activity promote hyperglycemia, not only by increased glucose production by the liver but also by reduced glucose uptake by muscle and adipose tissue, and also may contribute directly to NASH [61]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.